Clinical Trial Update: Perceived Changes in Anxiety Symptom Burden During Treatment With Bryophyllum Pinnatum and Tolerability [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating Bryophyllum pinnatum for anxiety symptoms has completed. The update notes perceived changes in anxiety burden and tolerability…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders

Drugs mentioned

• Bryophyllum pinnatum (Bryophyllum pinnatum extract)

Snippet

Sponsor: Markus Schlemmer | Conditions: Anxiety Symptoms | Phase 4 | Status: COMPLETED